Skip to main content
Erschienen in: Journal of General Internal Medicine 2/2020

26.10.2020 | Original Research

Rethinking How We Measure Costs in Implementation Research

verfasst von: Todd H. Wagner, PhD

Erschienen in: Journal of General Internal Medicine | Sonderheft 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Hospitals and other health care delivery organizations are sometimes resistant to implementing evidence‐based programs, citing unknown budgetary implications.

Objective

In this paper, I discuss challenges when estimating health care costs in implementation research.

Design

A case study with intensive care units highlights how including fixed costs can cloud a short‐term analysis.

Participants

None.

Interventions

None.

Main Measures

Health care costs, charges and payments.

Key Results

Cost data should accurately reflect the opportunity costs for the organization(s) providing care. Opportunity costs are defined as the benefits foregone because the resources were not used in the next best alternative. Because there is no database of opportunity costs, cost studies rely on accounting data, charges, or payments as proxies. Unfortunately, these proxies may not reflect the organization’s opportunity costs, especially if the goal is to understand the budgetary impact in the next few years.

Conclusions

Implementation researchers should exclude costs that are fixed in the time period of observation because these assets (e.g., space) cannot be used in the next best alternative. In addition, it is common to use costs from accounting databases where we implicitly assume health care providers are uniformly efficient. If providers are not operating efficiently, especially if there is variation in their efficiency, then this can create further problems. Implementation scientists should be judicious in their use of cost estimates from accounting data, otherwise research results can misguide decision makers.
Literatur
1.
Zurück zum Zitat Owens DK, Qaseem A, Chou R, Shekelle P. High-value, cost-conscious health care: concepts for clinicians to evaluate the benefits, harms, and costs of medical interventions. Ann Intern Med. 2011;154(3):174-180.CrossRef Owens DK, Qaseem A, Chou R, Shekelle P. High-value, cost-conscious health care: concepts for clinicians to evaluate the benefits, harms, and costs of medical interventions. Ann Intern Med. 2011;154(3):174-180.CrossRef
2.
Zurück zum Zitat Neumann P, Sanders G, Russell L, Siegel J, Ganiats T, eds. Cost-effectiveness in Health and Medicine. Oxford University Press; 2016. Neumann P, Sanders G, Russell L, Siegel J, Ganiats T, eds. Cost-effectiveness in Health and Medicine. Oxford University Press; 2016.
3.
Zurück zum Zitat Tan-Torres Edejer T, Baltussen R, Adam T, et al., eds. WHO Guide to Cost Effectiveness Analysis. Geneva, Switzerland: World Health Oranization; 2003. Tan-Torres Edejer T, Baltussen R, Adam T, et al., eds. WHO Guide to Cost Effectiveness Analysis. Geneva, Switzerland: World Health Oranization; 2003.
4.
Zurück zum Zitat Shwartz M, Young DW, Siegrist R. The ratio of costs to charges: how good a basis for estimating costs? Inquiry. 1995;32(4):476-481.PubMed Shwartz M, Young DW, Siegrist R. The ratio of costs to charges: how good a basis for estimating costs? Inquiry. 1995;32(4):476-481.PubMed
5.
Zurück zum Zitat Palmer S, Raftery J. Economic Notes: opportunity cost. Br Med J. 1999;318(7197):1551-1552.CrossRef Palmer S, Raftery J. Economic Notes: opportunity cost. Br Med J. 1999;318(7197):1551-1552.CrossRef
6.
Zurück zum Zitat Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-Effectiveness in Health and Medicine. Oxford: Oxford University Press; 1996. Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-Effectiveness in Health and Medicine. Oxford: Oxford University Press; 1996.
7.
Zurück zum Zitat Luce BR, Manning WG, Siegel JE, Lipscomb J. Estimating Costs in Cost Effectiveness Analysis. In: Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press; 1996:176-213. Luce BR, Manning WG, Siegel JE, Lipscomb J. Estimating Costs in Cost Effectiveness Analysis. In: Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press; 1996:176-213.
8.
Zurück zum Zitat Basu A. Estimating Costs and Valuations of Non-Health Benefits in Cost-Effectiveness Analysis. In: Neuman P, Sanders G, Russell LB, Siegel JE, Ganiats TG, eds. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press; 2016:201-235.CrossRef Basu A. Estimating Costs and Valuations of Non-Health Benefits in Cost-Effectiveness Analysis. In: Neuman P, Sanders G, Russell LB, Siegel JE, Ganiats TG, eds. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press; 2016:201-235.CrossRef
9.
Zurück zum Zitat Halpern NA, Pastores SM. Critical care medicine in the United States 2000-2005: an analysis of bed numbers, occupancy rates, payer mix, and costs. Crit Care Med. 2010;38(1):65-71.CrossRef Halpern NA, Pastores SM. Critical care medicine in the United States 2000-2005: an analysis of bed numbers, occupancy rates, payer mix, and costs. Crit Care Med. 2010;38(1):65-71.CrossRef
10.
Zurück zum Zitat Gooch RA, Kahn JM. ICU bed supply, utilization, and health care spending: an example of demand elasticity. JAMA. 2014;311(6):567-568.CrossRef Gooch RA, Kahn JM. ICU bed supply, utilization, and health care spending: an example of demand elasticity. JAMA. 2014;311(6):567-568.CrossRef
11.
Zurück zum Zitat Chen LM, Render M, Sales A, Kennedy EH, Wiitala W, Hofer TP. Intensive care unit admitting patterns in the Veterans Affairs health care system. Arch Intern Med. 2012;172(16):1220-1226.CrossRef Chen LM, Render M, Sales A, Kennedy EH, Wiitala W, Hofer TP. Intensive care unit admitting patterns in the Veterans Affairs health care system. Arch Intern Med. 2012;172(16):1220-1226.CrossRef
12.
Zurück zum Zitat Chang DW, Dacosta D, Shapiro MF. Priority Levels in Medical Intensive Care at an Academic Public Hospital. JAMA Intl Med. 2017;177(2):280-281.CrossRef Chang DW, Dacosta D, Shapiro MF. Priority Levels in Medical Intensive Care at an Academic Public Hospital. JAMA Intl Med. 2017;177(2):280-281.CrossRef
13.
Zurück zum Zitat Dasta JF, McLaughlin TP, Mody SH, Piech CT. Daily cost of an intensive care unit day: the contribution of mechanical ventilation. Crit Care Med. 2005;33(6):1266-1271.CrossRef Dasta JF, McLaughlin TP, Mody SH, Piech CT. Daily cost of an intensive care unit day: the contribution of mechanical ventilation. Crit Care Med. 2005;33(6):1266-1271.CrossRef
14.
Zurück zum Zitat Chiou H, Jopling JK, Scott JY, et al. Detecting organisational innovations leading to improved ICU outcomes: a protocol for a double-blinded national positive deviance study of critical care delivery. BMJ Open. 2017;7(6):e015930.CrossRef Chiou H, Jopling JK, Scott JY, et al. Detecting organisational innovations leading to improved ICU outcomes: a protocol for a double-blinded national positive deviance study of critical care delivery. BMJ Open. 2017;7(6):e015930.CrossRef
15.
Zurück zum Zitat Arrow K. Uncertainty and the welfare economics of medical care. AER. 1963;53(5):941-973. Arrow K. Uncertainty and the welfare economics of medical care. AER. 1963;53(5):941-973.
16.
Zurück zum Zitat Garber AM, Phelps CE. Economic foundations of cost-effectiveness analysis. J Health Econ. 1997;16(1):1-31.CrossRef Garber AM, Phelps CE. Economic foundations of cost-effectiveness analysis. J Health Econ. 1997;16(1):1-31.CrossRef
17.
Zurück zum Zitat Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med. 1977;296(13):716-721.CrossRef Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med. 1977;296(13):716-721.CrossRef
18.
Zurück zum Zitat Drummond MF, O’Brien B, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Second Edition ed. Oxford: Oxford University Press; 1997. Drummond MF, O’Brien B, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Second Edition ed. Oxford: Oxford University Press; 1997.
19.
Zurück zum Zitat Bryan S, Mitton C, Donaldson C. Breaking the addiction to technology adoption. Health Econ. 2014;23(4):379-383.CrossRef Bryan S, Mitton C, Donaldson C. Breaking the addiction to technology adoption. Health Econ. 2014;23(4):379-383.CrossRef
20.
Zurück zum Zitat Hwang J, Christensen CM. Disruptive innovation in health care delivery: a framework for business-model innovation. Health Aff. 2008;27(5):1329-1335.CrossRef Hwang J, Christensen CM. Disruptive innovation in health care delivery: a framework for business-model innovation. Health Aff. 2008;27(5):1329-1335.CrossRef
21.
Zurück zum Zitat Humphreys K, Wagner TH, Gage M. If substance use disorder treatment more than offsets its costs, why don’t more medical centers want to provide it? A budget impact analysis in the Veterans Health Administration. J Subst Abuse Treat. 2011;41(3):243-251.CrossRef Humphreys K, Wagner TH, Gage M. If substance use disorder treatment more than offsets its costs, why don’t more medical centers want to provide it? A budget impact analysis in the Veterans Health Administration. J Subst Abuse Treat. 2011;41(3):243-251.CrossRef
22.
Zurück zum Zitat Ettner SL, Huang D, Evans E, et al. Benefit-cost in the California treatment outcome project: does substance abuse treatment “pay for itself”? Health Serv Res. 2006;41(1):192-213.CrossRef Ettner SL, Huang D, Evans E, et al. Benefit-cost in the California treatment outcome project: does substance abuse treatment “pay for itself”? Health Serv Res. 2006;41(1):192-213.CrossRef
23.
Zurück zum Zitat Basu A. Estimating Costs and Valuations of Non-Health Benefits in Cost-Effectiveness Analysis In: Neumann P, Sanders G, Russell LB, Siegel JE, Ganiats TG, eds. Cost-Effectiveness in Health and Medicine. Oxford University Press; 2016. Basu A. Estimating Costs and Valuations of Non-Health Benefits in Cost-Effectiveness Analysis In: Neumann P, Sanders G, Russell LB, Siegel JE, Ganiats TG, eds. Cost-Effectiveness in Health and Medicine. Oxford University Press; 2016.
24.
Zurück zum Zitat Barnett PG. An improved set of standards for finding cost for cost-effectiveness analysis. Med Care. 2009;47(7 Suppl 1):S82-88.CrossRef Barnett PG. An improved set of standards for finding cost for cost-effectiveness analysis. Med Care. 2009;47(7 Suppl 1):S82-88.CrossRef
25.
Zurück zum Zitat Kaplan RS, Porter ME. How to solve the cost crisis in health care. Harv Bus Rev. 2011;89(9):46-52, 54, 56-61 passim.PubMed Kaplan RS, Porter ME. How to solve the cost crisis in health care. Harv Bus Rev. 2011;89(9):46-52, 54, 56-61 passim.PubMed
26.
Zurück zum Zitat Adang EM, Wensing M. Economic barriers to implementation of innovations in health care: is the long run-short run efficiency discrepancy a paradox? Health Policy. 2008;88(2-3):236-242.CrossRef Adang EM, Wensing M. Economic barriers to implementation of innovations in health care: is the long run-short run efficiency discrepancy a paradox? Health Policy. 2008;88(2-3):236-242.CrossRef
27.
Zurück zum Zitat Valdmanis VG, Rosko MD, Mutter RL. Hospital quality, efficiency, and input slack differentials. Health Serv Res. 2008;43(5 Pt 2):1830-1848.CrossRef Valdmanis VG, Rosko MD, Mutter RL. Hospital quality, efficiency, and input slack differentials. Health Serv Res. 2008;43(5 Pt 2):1830-1848.CrossRef
28.
Zurück zum Zitat Bloom N, Van Reenen J. Measuring and Explaining Management Practices Across Firms and Countries. Q J Econ. 2007;122(4):1351-1408.CrossRef Bloom N, Van Reenen J. Measuring and Explaining Management Practices Across Firms and Countries. Q J Econ. 2007;122(4):1351-1408.CrossRef
29.
Zurück zum Zitat Neumann PJ, Stone PW, Chapman RH, Sandberg EA, Bell CM. The quality of reporting in published cost-utility analyses, 1976-1997. Ann Intern Med. 2000;132(12):964-972.CrossRef Neumann PJ, Stone PW, Chapman RH, Sandberg EA, Bell CM. The quality of reporting in published cost-utility analyses, 1976-1997. Ann Intern Med. 2000;132(12):964-972.CrossRef
30.
Zurück zum Zitat Mauskopf J, Sullivan S, Annemans L. Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices – Budget Impact Analysis. Value Health. 2007;10:336-347.CrossRef Mauskopf J, Sullivan S, Annemans L. Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices – Budget Impact Analysis. Value Health. 2007;10:336-347.CrossRef
31.
Zurück zum Zitat Sullivan SD, Mauskopf JA, Augustovski F, et al. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force. Value Health. 2014;17(1):5-14.CrossRef Sullivan SD, Mauskopf JA, Augustovski F, et al. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force. Value Health. 2014;17(1):5-14.CrossRef
32.
Zurück zum Zitat Roberts SLE, Healey A, Sevdalis N. Use of health economic evaluation in the implementation and improvement science fields-a systematic literature review. Implement Sci. 2019;14(1):72.CrossRef Roberts SLE, Healey A, Sevdalis N. Use of health economic evaluation in the implementation and improvement science fields-a systematic literature review. Implement Sci. 2019;14(1):72.CrossRef
33.
Zurück zum Zitat Reeves P, Edmunds K, Searles A, Wiggers J. Economic evaluations of public health implementation-interventions: a systematic review and guideline for practice. Public Health. 2019;169:101-113.CrossRef Reeves P, Edmunds K, Searles A, Wiggers J. Economic evaluations of public health implementation-interventions: a systematic review and guideline for practice. Public Health. 2019;169:101-113.CrossRef
34.
Zurück zum Zitat Dopp AR, Mundey P, Beasley LO, Silovsky JF, Eisenberg D. Mixed-method approaches to strengthen economic evaluations in implementation research. Implement Sci. 2019;14(1):2.CrossRef Dopp AR, Mundey P, Beasley LO, Silovsky JF, Eisenberg D. Mixed-method approaches to strengthen economic evaluations in implementation research. Implement Sci. 2019;14(1):2.CrossRef
35.
Zurück zum Zitat Smith M, Saunders R, Stuckhardt L, McGinnis JM, eds. Best Care at Lower Cost: The Path to Continuously Learning Health Care in America. Washington, D.C.: The National Academies Press; 2012. Institute of Medicine, ed. Smith M, Saunders R, Stuckhardt L, McGinnis JM, eds. Best Care at Lower Cost: The Path to Continuously Learning Health Care in America. Washington, D.C.: The National Academies Press; 2012. Institute of Medicine, ed.
Metadaten
Titel
Rethinking How We Measure Costs in Implementation Research
verfasst von
Todd H. Wagner, PhD
Publikationsdatum
26.10.2020
Verlag
Springer International Publishing
Erschienen in
Journal of General Internal Medicine / Ausgabe Sonderheft 2/2020
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-020-06104-6

Weitere Artikel der Sonderheft 2/2020

Journal of General Internal Medicine 2/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.